迪诺芬/阿片类受体系统在高过敏症/高卡提菲症和成的界面上
Renata C N Marchette1, Leandro F Vendruscolo2, George F Koob1
1Neurobiology of Addiction Section, Integrative Neuroscience Research Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, BRC Room 08A505.19, 251 Bayview Blvd, Baltimore, MD 21224 USA.
Current addiction reports
|March 24, 2025
概括
迪诺芬/κ-阿片类受体 (KOR) 系统与阿片类药物戒断症状 (如过敏症和过高卡提菲亚) 有关. 针对这个系统显示了成治疗的治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 成研究 研究成研究
背景情况:
- 药物成包括强迫性使用和戒断症状,如过敏症和过敏症.
- 这些症状会对药物使用障碍的治疗和康复产生负面影响.
- 迪诺芬/κ-阿片类受体 (KOR) 系统是奖励和压力电路中的关键神经生物学参与者.
研究的目的:
- 审查关于在阿片类药物戒断引起的高和高卡提菲亚中使用迪诺芬/KOR信号的临床前证据.
- 探索诺芬/KOR系统在调节疼痛,负面影响和成行为中的作用.
主要方法:
- 检讨了研究dynorphin/KOR信号的临床前研究.
- 在阿片类药物依赖模型中对药理学和遗传干预的分析.
主要成果:
- 迪诺芬/KOR系统调节减轻了阿片类药物戒断的迹象.
- 针对迪诺芬/KOR系统的干预措施可以减少体质和动机性戒断症状.
- 这个系统会影响类似上的行为.
结论:
- 迪诺芬/KOR系统在治疗阿片类药物使用障碍方面具有治疗潜力.
- 了解它的作用为新的治疗策略提供了洞察力.
- 需要对性二态和有针对性的干预进行进一步的研究.
相关概念视频
Opioid Receptors: Overview
408
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
408
Analgesia and Pain Management
411
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
411
Opioid Analgesics: Synthetic and Semisynthetic Opioids
195
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
195
Opioid Analgesics: Morphine and Other Natural Cogeners
150
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
150
Nociception
27.6K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
27.6K
Drug Abuse and Addiction: Pharmacological Phenomena
417
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
417


